The expression level of interleukin-6 affects the cellular sensitivity to PDT, and the combination of PDT and interleukin-6 may serve as a novel strategy for the therapy of Lewis lung carcinoma [12]. This evidence concerns the gene IL6 and Carcinoma, Lewis Lung.